Host-Fungal Interactions and Immune Mechanisms

Host-fungal interactions and immune mechanisms is the area of mycology concerned with how the human host detects, contains, and is harmed by fungi, and reciprocally how fungal pathogens establish themselves in host tissue. It links the virulence attributes of the fungus to the innate and adaptive immune programmes that recognise fungal cell-wall structures, and to the states of immune deficiency that convert ordinarily harmless or contained fungi into life-threatening invasive disease.

Definition

Host-fungal interaction refers to the bidirectional relationship in which fungal pathogenicity attributes and host immune defences jointly determine whether exposure results in commensalism, colonisation, controlled infection, or invasive disease.

Scope

The area orients the reader across four linked themes: the virulence factors and pathogenic strategies fungi use to colonise and invade; the innate immune sensing and effector responses that form the first line of antifungal defence; the adaptive, T-cell-mediated responses (especially Th17/Th1) that confer durable protection; and the conditions of immunocompromise that shape susceptibility. It treats antifungal immunity as a reference and educational subject within microbiology and immunology, not as clinical management guidance.

Sub-topics

• Adaptive Immunity and Th Responses to Fungi
• Fungal Virulence Factors and Pathogenesis
• Immunocompromise and Susceptibility to Fungal Infection
• Innate Immunity Against Fungi

Core questions

• How does the immune system distinguish a colonising or commensal fungus from an invading one?
• Which fungal structures are recognised by host receptors, and which effector cells clear fungi?
• Why do specific immune defects predispose to specific fungal infections?
• How do fungal virulence factors subvert or evade host immunity?

Key concepts

• Fungal virulence and pathogenicity attributes
• Pattern-recognition of fungal cell-wall components (beta-glucan, mannan, chitin)
• Innate effector cells (neutrophils, macrophages, dendritic cells)
• C-type lectin receptors and Dectin-1 signalling
• Th17 and Th1 adaptive responses
• Inborn errors of immunity and acquired immunosuppression
• Opportunistic versus primary fungal pathogens

Mechanisms

Recognition begins when innate receptors sense conserved fungal cell-wall components: C-type lectin receptors such as Dectin-1 detect beta-glucan, while Toll-like receptors and other lectins detect mannans and other ligands, triggering phagocytosis, reactive oxygen production, and cytokine release. Neutrophils and macrophages provide front-line killing, and dendritic cells bridge to adaptive immunity by instructing CD4+ T-cell differentiation. Protective adaptive immunity to many fungi is dominated by Th17 and Th1 responses, with IL-17 mobilising neutrophils at mucosal surfaces. Fungal pathogens counter these defences with virulence attributes—morphological switching, cell-wall remodelling that masks immunostimulatory glucan, biofilm formation, and secreted enzymes—so that the outcome of infection reflects the balance between fungal pathogenicity and host immune competence (brown-2012; netea-2015; lionakis-2018).

Clinical relevance

Understanding antifungal immunity explains why invasive fungal disease clusters in particular patient groups—those with neutropenia, T-cell deficiency, or specific genetic immune defects—and why different defects map to different infections. This area describes the immunological basis of fungal susceptibility for educational orientation; it is not a source of diagnostic thresholds or treatment recommendations for individual patients.

Epidemiology

Serious fungal infections affect a large global population, with millions of cases of invasive and chronic mycoses estimated annually, concentrated among immunocompromised hosts; population-level estimates have been compiled to highlight the under-recognised burden of fungal disease (bongomin-2017).

Evidence & guidelines

The conceptual framework of this area rests on narrative and mechanistic reviews synthesising basic immunology and human cohort observations (netea-2015; lionakis-2018). Clinical management of specific mycoses is governed by separate infectious-disease guidelines that are outside the scope of this reference entry.

History

Antifungal immunology matured later than antibacterial immunology, gaining momentum in the 2000s and 2010s with the identification of Dectin-1 and other C-type lectin receptors as dedicated fungal sensors and the recognition of the Th17 axis in mucosal antifungal defence. The discovery of inborn errors of immunity that selectively predispose to fungal infection clarified the non-redundant roles of particular immune pathways, and surveys of the global burden of fungal disease drew clinical and public-health attention to the field (brown-2012; netea-2015; lionakis-2018).

Key figures

• Gordon D. Brown
• Mihai G. Netea
• Neil A. R. Gow
• Michail S. Lionakis
• Stuart M. Levitz

Seminal works

• brown-2012
• netea-2015
• lionakis-2018

Frequently asked questions

What is meant by host-fungal interaction?

It is the two-way relationship between a fungus and its host, in which fungal virulence traits and host immune defences together determine whether exposure leads to harmless carriage, controlled infection, or invasive disease.

Why are fungal infections mostly a problem for immunocompromised people?

Intact innate and adaptive immunity normally contains fungi; when key defences such as neutrophils or T-cell responses are impaired, ordinarily contained or commensal fungi can invade and cause serious disease.